← Back to Screener
GridAI Technologies Corp. Common Stock (GRDX)
Price$6.35
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)104.45%
Price vs S&P 500 (4W)85.68%
VGM Score96.34
Market Capitalization$42.25M
All Metrics
Book Value / Share (Quarterly)$3.68
P/TBV (Annual)8.38x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-1.09
Price vs S&P 500 (YTD)28.11%
EPS (TTM)$-3.95
10-Day Avg Trading Volume0.18M
EPS Excl Extra (TTM)$-3.95
EPS (Annual)$-3.95
ROI (Annual)-24.84%
Gross Margin (Annual)-1813.60%
Cash / Share (Quarterly)$0.06
ROA (Last FY)-13.17%
EBITD / Share (TTM)$-4.23
Cash Flow / Share (Annual)$-1.35
P/B Ratio1.88x
P/B Ratio (Quarterly)0.30x
Net Income / Employee (Annual)$-3,196,300
Net Interest Coverage (TTM)-12.53x
ROA (TTM)-10.96%
EPS Incl Extra (Annual)$-3.95
Current Ratio (Annual)0.17x
Quick Ratio (Quarterly)0.14x
3-Month Avg Trading Volume0.13M
52-Week Price Return329.05%
Tangible BV / Share (Quarterly)$0.20
P/S Ratio (Annual)1165.45x
Asset Turnover (Annual)0.00x
52-Week High$6.93
EPS Excl Extra (Annual)$-3.95
26-Week Price Return112.37%
Quick Ratio (Annual)0.16x
13-Week Price Return186.04%
Total Debt / Equity (Annual)0.09x
Current Ratio (Quarterly)0.16x
Enterprise Value$44.22M
Revenue / Employee (Annual)$18,100
Pretax Margin (Annual)-18317.30%
Cash / Share (Annual)$0.21
3-Month Return Std Dev124.26%
Net Income / Employee (TTM)$-4,342,700
ROE (Last FY)-26.96%
Net Interest Coverage (Annual)-8.48x
EPS Basic Excl Extra (Annual)$-3.95
Total Debt / Equity (Quarterly)0.10x
EPS Incl Extra (TTM)$-3.95
ROI (TTM)-18.13%
Revenue / Share (Annual)$0.02
Tangible BV / Share (Annual)$0.44
Price vs S&P 500 (52W)304.69%
Year-to-Date Return36.27%
5-Day Price Return-6.62%
EPS Normalized (Annual)$-3.95
Net Profit Margin (Annual)-17634.90%
Month-to-Date Return13.19%
EBITD / Share (Annual)$-4.38
Operating Margin (Annual)-19540.52%
EPS Basic Excl Extra (TTM)$-3.95
P/TBV (Quarterly)5.58x
P/B Ratio (Annual)0.66x
Book Value / Share (Annual)$5.61
Price vs S&P 500 (13W)177.78%
Beta1.75x
ROE (TTM)-18.69%
52-Week Low$1.08
mGradeA
vgmGradeA
Show chart for
Earnings Surprise History
Q1 26-0.82est. —
Analyst Recommendations
Dec 2024
Jan 2025
Feb 2025
Mar 2025
4.00
2.17
2.17
2.17
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
GRDXGridAI Technologies Corp. Common Stock | — | — | A | $6.35 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
GridAI Technologies Corp is a late-stage biopharmaceutical company developing non-systemic therapies for gastrointestinal diseases. Key programs include latiglutenase for celiac disease (Phase 3-ready), capeserod for gastroparesis, and adrulipase for pancreatic insufficiency. The company focuses on addressing unmet medical needs in GI health.